{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:26:28Z","timestamp":1771514788823,"version":"3.50.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.vaccine.2004.03.032","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T09:36:44Z","timestamp":1082021804000},"page":"3658-3668","source":"Crossref","is-referenced-by-count":296,"title":["Aluminium adjuvants\u2014in retrospect and prospect"],"prefix":"10.1016","volume":"22","author":[{"given":"Erik B","family":"Lindblad","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.03.032_BIB1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1700290106","article-title":"Immunological notes XVII to XXIV","volume":"29","author":"Glenny","year":"1926","journal-title":"J. Pathol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700340214","article-title":"Rate of disappearance of diphtheria toxoid injected into rabbits and guinea-pigs: toxoid precipitated with alum","volume":"34","author":"Glenny","year":"1931","journal-title":"J. Pathol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB3","unstructured":"Holt LB. Developments in diphtheria prophy1axis. London: Wm. Heinemann Ltd; 1950."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB4","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/cber.19310640851","article-title":"\u00dcber die F\u00e4higkeit des Tonerde-Pr\u00e4parates B, Diphtherie-Toxin zu adsorbieren","volume":"64","author":"Maschmann","year":"1931","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/158350a0","article-title":"Purification and adsorption of diphtheria toxoid","volume":"158","author":"Ericsson","year":"1946","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(47)90094-9","article-title":"Purified precipitated diphtheria toxoid of constant composition","volume":"8","author":"Holt","year":"1947","journal-title":"Lancet (i)"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB7","doi-asserted-by":"crossref","unstructured":"Stewart-Tull DES. Recommandations for the assessment of adjuvants (immunomodulators). In: Gregoriadis G, Allison AC, Poste G, editors. Immunological adjuvants and vaccines. Plenum Publishing Corporation; 1989. p. 213\u201326.","DOI":"10.1007\/978-1-4757-0283-5_22"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2105\/AJPH.32.7.690","article-title":"Diphtheria immunization with fluid toxoid and alum-precipitated toxoid","volume":"32","author":"Volk","year":"1942","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB9","first-page":"6","article-title":"Study on Indian Cobra Venom toxoid","volume":"21","author":"Kawamura","year":"1989","journal-title":"Snake"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB10","first-page":"81","article-title":"Study on the immunogenicity of purified toxoid of Siamese Cobra (Naja Naja kaouthia) Venom","volume":"21","author":"Kawamura","year":"1989","journal-title":"Snake"},{"issue":"4","key":"10.1016\/j.vaccine.2004.03.032_BIB11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000233646","article-title":"Adjuvant effects of aluminium silicate on IgE and Ig G1 antibody production in mice","volume":"75","author":"Fujimaki","year":"1984","journal-title":"Int. Archs. Allergy. Appl. Immun."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0264-410X(91)90127-R","article-title":"The adjuvanticity of Algammulin, a new vaccine adjuvant","volume":"9","author":"Cooper","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3181\/00379727-116-29295","article-title":"New metabolizable immunological adjuvant for human use. Development and animal immune response","volume":"116","author":"Woodhour","year":"1964","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB14","first-page":"477","article-title":"Studies for safety of Adjuvant 65","volume":"30","author":"Hilleman","year":"1972","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB15","unstructured":"Hem JE, Roberson CE. Chemistry of aluminium in natural water. form and stability of aluminium hydroxide complexes in dilute solution. US Geological Survey Water-Supply Paper 1827-A. Washington DC: US Government Printing Office; 1967."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cber.19230560522","article-title":"\u00dcber ein Tonerde-Gel von der Formel Al (OH)3. II. Mitteilung \u00fcber Hydrate und Hydrogele","volume":"56","author":"Willst\u00e4tter","year":"1923","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/cber.19240570704","article-title":"\u00dcber die Hydroxide und ihre Hydrate in den verschiedenen Tonerde-Gelen. V. Mitteilung \u00fcber Hydrate und Hydrogele","volume":"57","author":"Willst\u00e4tter","year":"1924","journal-title":"Ber. Dtsch. Chem. Ges."},{"issue":"8","key":"10.1016\/j.vaccine.2004.03.032_BIB18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jps.2600650814","article-title":"Structure of aluminium hydroxide gel. Part I. Initial precipitate","volume":"65","author":"Nail","year":"1976","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.032_BIB19","first-page":"2","article-title":"Characterization of aluminium hydroxide for use as an adjuvant in parenteral vaccines","volume":"38","author":"Hem","year":"1984","journal-title":"J. Parent. Sci. Techn."},{"issue":"12","key":"10.1016\/j.vaccine.2004.03.032_BIB20","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1023\/A:1015994006859","article-title":"Aluminium compounds used as adjuvants in vaccines","volume":"7","author":"Shirodkar","year":"1990","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.vaccine.2004.03.032_BIB21","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jps.10166","article-title":"Measuring the surface area of aluminium hydroxide adjuvant","volume":"91","author":"Johnston","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB23","doi-asserted-by":"crossref","unstructured":"Weeke B, Weeke E, L\u00f8wenstein H. The adsorption of serum proteins to aluminium hydroxide gel examined by means of quantitative immunoelectrophoresis. In: Axelsen NH, editor. Quantitative immunoelectrophoresis. New developments and applications. Universitetsforlaget; 1975. p. 149\u201354.","DOI":"10.1111\/j.1365-3083.1975.tb03821.x"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB24","unstructured":"Lindblad EB. Aluminium adjuvants. In: Stewart-Tull, editor. The theory and practical application of adjuvants. New York: John Wiley & Sons; 1995. p. 21\u201335."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB25","unstructured":"Relyveld EH, Raynaud M. In: Williams CA, Chase MW, editors. Methods in immunology and immunochemistry, vol. IV. Academic Press, New York; 1977. p. 283\u201393."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcla.1860040210","article-title":"An enzyme-linked immunosorbent assay for the detection of antitetanus toxoid antibody using aluminium-adsorbed coating antigen","volume":"4","author":"Thiele","year":"1990","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0166-0934(89)90104-3","article-title":"In vitro assessment of viral antigen content in inactivated aluminium hydroxide adjuvanted vaccines","volume":"25","author":"Katz","year":"1989","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-1157(84)80051-7","article-title":"The aluminium content of biological products containing aluminium adjuvants: determination by atomic absorption spectrometry","volume":"12","author":"May","year":"1984","journal-title":"J. Biol. Stand."},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.032_BIB29","first-page":"143","article-title":"Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: Effect on antigen uptake and antigen presentation","volume":"61","author":"Mannhalter","year":"1985","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.vaccine.2004.03.032_BIB30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0264-410X(92)90369-U","article-title":"Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant","volume":"10","author":"Dillon","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB31","first-page":"435","article-title":"The comparative selectivity of adjuvants for humoral and cell-mediated immunity. Part II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund\u2019s incomplete and complete adjuvants, Alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin","volume":"39","author":"Bomford","year":"1980","journal-title":"Clin. exp. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.032_BIB32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3181\/00379727-156-39951","article-title":"Eosinophil response to alum adjuvants: involvement of T cells in non-antigen-dependent mechanisms","volume":"156","author":"Walls","year":"1977","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.vaccine.2004.03.032_BIB33","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.135.5.3463","article-title":"Selective regulation of chemotactic lymphokine production. Part I. Selective potentiation of eosinophil chemotactic lymphokine production in alum hydroxy gel- and Bordetella pertussis vaccine-treated guinea-pigs","volume":"135","author":"Sakata","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB34","first-page":"881","article-title":"Complement activation by aluminium and zirconium compounds","volume":"37","author":"Ramanathan","year":"1979","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2004.03.032_BIB35","first-page":"251","article-title":"A limited role of IL-1 in immune-enhancement by adjuvants","volume":"71","author":"Sagara","year":"1990","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.032_BIB36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0008-8749(89)90011-7","article-title":"Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles. The role of endogenous interleukin-l in proliferative responses","volume":"121","author":"Grun","year":"1989","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH 1 and TH 2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Ann. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2004.03.032_BIB38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/IAI.65.2.623-629.1997","article-title":"Adjuvant modulation of immune responses to tuberculosis subunit vaccines","volume":"65","author":"Lindblad","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2567.2003.01581.x","article-title":"Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12","volume":"108","author":"Pollock","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB40","first-page":"4481","article-title":"Adsorption to aluminium hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp 120","volume":"163","author":"Jankovic","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB41","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund\u2019s complete adjuvant, but continues to induce T helper 2 cytokine production","volume":"26","author":"Brewer","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB42","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4 or IL-13-mediated signalling","volume":"163","author":"Brewer","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF00430933","article-title":"Reversal of H-2-restricted hyporesponsiveness to human growth hormone by the use of aluminium hydroxide as adjuvant","volume":"21","author":"Bomford","year":"1985","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(89)90156-7","article-title":"Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies","volume":"121","author":"Kenney","year":"1989","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1084\/jem.138.1.306","article-title":"Hapten-specific IgE antibody responses in mice. I. Secondary IgE response in irradiated recipients of syngeneic primed spleen cells","volume":"138","author":"Hamaoka","year":"1973","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.032_BIB46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4269\/ajtmh.1988.38.515","article-title":"Induction of resistance to Schistosoma mansoni by immunization with subfractions of worms","volume":"38","author":"Knopf","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/eji.1830120413","article-title":"Protection against Schistosoma mansoni achieved by immunization with sonicated parasite","volume":"12","author":"Horowitz","year":"1982","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2004.03.032_BIB48","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4049\/jimmunol.129.4.1384","article-title":"Formation of IgE binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of Ig E binding factors formed by antigenic stimulation","volume":"129","author":"Uede","year":"1982","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2004.03.032_BIB49","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.129.4.1391","article-title":"Formation of IgE binding factors by rat T lymphocytes. VI. Cellular mechanisms for the formation of IgE-potentiating factor and IgE-suppressive factor by antigenic stimulation of antigen primed spleen cells","volume":"129","author":"Uede","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB50","unstructured":"Immunological Adjuvants. Technical Report Series 595. World Health Organization, Geneva; 1976."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB51","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/vr.85.14.378","article-title":"Avian infectious bronchitis: the protection afforded by an inactivated virus vaccine","volume":"85","author":"McDougall","year":"1969","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/vr.100.26.552","article-title":"Experiments with an inactivated hepatitis leptospirosis vaccine in vaccination programmes for dogs","volume":"100","author":"Wilson","year":"1977","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0007-1935(17)35786-X","article-title":"Early protection of pigs against foot-and-mouth disease","volume":"130","author":"Sellers","year":"1974","journal-title":"Br. Vet. J."},{"issue":"2","key":"10.1016\/j.vaccine.2004.03.032_BIB54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0034-5288(18)34458-8","article-title":"The Influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines","volume":"10","author":"Hyslop","year":"1969","journal-title":"Res. Vet. Sci."},{"issue":"5","key":"10.1016\/j.vaccine.2004.03.032_BIB55","first-page":"127","article-title":"Comparative evaluation of the potency of beta-propiolactone inactivated Newcastle disease vaccines prepared from a lentogenic and a velogenic strain","volume":"77","author":"Pini","year":"1965","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0034-5288(18)32603-1","article-title":"Comparison of alum-adsorbed or non-alum-adsorbed oil emulsion vaccines containing, either pilate or non-pilate Bacteroides nodosus cells in inducing and maintaining resistance of sheep to experimental foot rot","volume":"30","author":"Thorley","year":"1981","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0034-5288(18)33008-X","article-title":"Vaccination against canine bordetellosis using an aluminium hydroxide adjuvant vaccine","volume":"25","author":"McCandlish","year":"1978","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB58","first-page":"65","article-title":"Protective antigens in bovine pasteurellosis","volume":"26","author":"Nagy","year":"1974","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00480169.1979.34637","article-title":"Leptospira interrogans serovar. pomona vaccines with different adjuvants in cattle","volume":"27","author":"Ris","year":"1979","journal-title":"New Zealand Vet. J."},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.032_BIB60","first-page":"366","article-title":"Immunogenic effects of culture-derived exoantigens of Cooperia punctata on calves before and after challenge exposure with infective larvae","volume":"49","author":"Leland","year":"1988","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.032_BIB61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-4894(89)90009-X","article-title":"Nematospiroides dubius: influence of adjuvants on immunity in mice vaccinated with antigens isolated by affinity chromatography from adult worms","volume":"68","author":"Monroy","year":"1989","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.032_BIB62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0031182000055839","article-title":"Resistance of Onchocerca lienalis microfilariae in mice conferred by egg antigens of homologous and heterologous Onchocerca species","volume":"94","author":"Carlow","year":"1987","journal-title":"Parasitology"},{"issue":"11","key":"10.1016\/j.vaccine.2004.03.032_BIB63","first-page":"2396","article-title":"Inocu1ation of pigs against Trichinella spiralis using larval excretory-secretory antigens","volume":"47","author":"Gamble","year":"1986","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB64","unstructured":"Randrup A. Physico-chemical and immunological studies on the virus of foot-and-mouth disease and its host tissue microsomes. Doctoral thesis. Munksgaard, Copenhagen; 1957."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0264-410X(91)90154-X","article-title":"Predicting the adsorption of proteins by aluminium-containing adjuvants","volume":"9","author":"Seeber","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jcis.1995.1233","article-title":"Effect of anions on model aluminium-adjuvant-containing vaccines","volume":"172","author":"Rinella","year":"1995","journal-title":"J. Colloid Interf. Sci."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jcis.1998.5648","article-title":"Effect of pH on the elution of model antigens from aluminium-containing adjuvants","volume":"205","author":"Rinella","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/jcis.1997.5230","article-title":"Elutability of proteins from aluminium-containing vaccine adjuvants by treatment with surfactants","volume":"197","author":"Rinella","year":"1998","journal-title":"J. Colloid Interface Sci."},{"issue":"5","key":"10.1016\/j.vaccine.2004.03.032_BIB69","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.109.5.1138","article-title":"A predictive equation for the primary immune response of mice to adsorbed tetanus toxoid as a function of dose of antigen and dose of adjuvant","volume":"109","author":"Levine","year":"1972","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB70","first-page":"615","article-title":"The early primary immune response to adsorbed tetanus toxoid in man","volume":"49","author":"MacLennan","year":"1973","journal-title":"Bull. WHO"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB71","unstructured":"Schmidt G. The adjuvant effect of aluminium hydroxide in influenza Vaccine. In: Symp. Series Immunobiol. Standard, vol. 6. New York: Karger, Basel; 1967.p. 275\u201382."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1699-0463.1988.tb05299.x","article-title":"On the effect of Al(OH)3 as an immunological adjuvant","volume":"96","author":"Jensen","year":"1988","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB73","unstructured":"Relyveld EH. In: Nistico G, Mastroeni P, Pitzurra M, editors. Proceedings of the Seventh International Conference on Tetanus. Roma: Gangemi Publ. Co.; 1985. p. 215\u201327."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB74","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB75","unstructured":"Ph. Eur. 3. Ed. Vaccines for human use; 1997. p. 1697."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB76","unstructured":"Code of Federal Regulations 21, vol. 7: sec. 610.15 (Constituent Materials), revised April 1, 2003."},{"issue":"8629","key":"10.1016\/j.vaccine.2004.03.032_BIB77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(89)91425-6","article-title":"Geographical relation between Alzheimers disease and aluminium in drinking water","volume":"1","author":"Martyn","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB78","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0264-410X(97)00041-8","article-title":"In vivo absorption of aluminium containing vaccines using 26Al","volume":"15","author":"Flarend","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.032_BIB79","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinids\/2.3.370","article-title":"Vaccine adjuvants","volume":"2","author":"Edelman","year":"1980","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB80","first-page":"343","article-title":"Aluminium compounds as adjuvants for vaccines and toxoids in man: a review","volume":"57","author":"Aprile","year":"1966","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB81","doi-asserted-by":"crossref","unstructured":"Collier LH, Polakoff S, Mortimer J, Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet 1979:1364\u20137.","DOI":"10.1016\/S0140-6736(79)92006-3"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.5645.663","article-title":"Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants","volume":"1","author":"Butler","year":"1969","journal-title":"Brit. Med. J."},{"issue":"14","key":"10.1016\/j.vaccine.2004.03.032_BIB83","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/0264-410X(95)00023-T","article-title":"Effects of aluminium adjuvant on systemic reactions of lipopolysaccharides in swine","volume":"13","author":"Norimatsu","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB84","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0264-410X(00)00394-7","article-title":"Detoxification of endotoxin by aluminium hydroxide adjuvant","volume":"19","author":"Shi","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB85","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0536.1986.tb01368.x","article-title":"Contact sensitivity to aluminium","volume":"15","author":"B\u00f6hler-Sommeregger","year":"1986","journal-title":"Contact Dermat."},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.032_BIB86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB87","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1398-9995.1985.tb00249.x","article-title":"Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts","volume":"40","author":"Frost","year":"1985","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB88","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB89","unstructured":"Batista A, Lindblad EB, Analyzing toxicological aspects of immunological adjuvants for vaccine and experimental use, 2003, submitted for publication."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB90","unstructured":"Chaby R, Caroff M, Lipopolysaccharides of Bordetella pertussis endotoxin. in: Wardlaw AC, Parton P, editors. Pathogenesis and immunity in pertussis. New York: Wiley; 1988. p. 247\u201371."},{"issue":"5","key":"10.1016\/j.vaccine.2004.03.032_BIB91","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.100.5.1139","article-title":"Lack of adjuvant effect of AlPO4 on purified influenza virus hemagglutinins in man","volume":"100","author":"Davenport","year":"1968","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB92","first-page":"29","article-title":"The present status of field and laboratory studies of typhoid and paratyphoid vaccines","volume":"32","author":"Cvjetanovic","year":"1965","journal-title":"Bull. WHO"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB93","first-page":"1","article-title":"Immune response to uncoupled peptides of foot-and-mouth disease virus","volume":"61","author":"Francis","year":"1987","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB94","doi-asserted-by":"crossref","unstructured":"Bomford R, Aluminium salts: perspectives in their use as adjuvants. In: Gregoriadis G, Allison AC, Poste G, editors. Immunological adjuvants and vaccines. Plenum Publishing Corp.; 1989. p. 35\u201341.","DOI":"10.1007\/978-1-4757-0283-5_5"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB95","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/0022-1317-66-11-2347","article-title":"Immunological priming with synthetic peptides of foot-and-mouth disease virus","volume":"66","author":"Francis","year":"1985","journal-title":"J. Gen. Vir."},{"issue":"2","key":"10.1016\/j.vaccine.2004.03.032_BIB96","first-page":"311","article-title":"Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia","volume":"65","author":"Lew","year":"1988","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.032_BIB97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-1759(89)90190-7","article-title":"The influence of different adjuvants on the immune response to a synthetic peptide comprising amino acid residues 9\u201321 of herpes simplex virus Type 1","volume":"124","author":"Geerligs","year":"1989","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB98","unstructured":"Goldenthal KL, Cavagnaro JA, Alving C, Vogel FR, Safety evaluation of vaccine adjuvants. NCVDG Working Groups. AIDS Res. Human Retroviruses 1993;9(Suppl 1):s47\u201351."},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.032_BIB99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0015-0282(16)49469-0","article-title":"Enhancement of anti-gonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin","volume":"46","author":"Talwar","year":"1986","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.vaccine.2004.03.032_BIB100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1095\/biolreprod32.4.761","article-title":"Fertility control in the bitch by active immunization with porcine Zonae Pellucidae. Use of different adjuvants and patterns of estradio1 and progesterone levels in estrous cycles","volume":"32","author":"Mahi-Brown","year":"1985","journal-title":"Biol. Reprod."},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2004.03.032_BIB101","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0264-410X(99)00264-9","article-title":"The immunogenicity in humans of a botulinum type F vaccine","volume":"18","author":"Montgomery","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB102","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of Clostridium botulinum, IX. Immunologic response of man to purified pentavalent ABCDE botulinum toxoid","volume":"90","author":"Fiock","year":"1963","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0264-410X(99)00151-6","article-title":"Enhancement of DNA vaccine potency using conventional aluminum adjuvants","volume":"18","author":"Ulmer","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.032_BIB104","doi-asserted-by":"crossref","unstructured":"Kwissa M, Lindblad EB, Schirmbeck R, Reimann J. Co-delivery of a DNA vaccine and a protein vaccine with aluminium phosphate stimulates a potent and multivalent immune response. J Mol Med 2003;81:502\u201310.","DOI":"10.1007\/s00109-003-0452-9"},{"issue":"7","key":"10.1016\/j.vaccine.2004.03.032_BIB105","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.4049\/jimmunol.164.7.3476","article-title":"Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression","volume":"164","author":"Nomura","year":"2000","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2004.03.032_BIB106","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1566524023362159","article-title":"Toll-like receptor 9, CpG DNA and innate immunity","volume":"2","author":"Ashkar","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.vaccine.2004.03.032_BIB107","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0264-410X(02)00531-5","article-title":"Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro","volume":"21","author":"Sun","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T08:02:14Z","timestamp":1682668934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":107,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0264410X04002750"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.03.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}